123158-73-6

Basic information

• Product Name: 1-chloro-3-ethyl-5-nitroBenzene
• Synonyms: 1-chloro-3-ethyl-5-nitroBenzene
• CAS NO: 123158-73-6
• Molecular Weight: 0
• Mol File: 123158-73-6.mol

Chemical Properties

• CAS DataBase Reference: 1-chloro-3-ethyl-5-nitroBenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-chloro-3-ethyl-5-nitroBenzene(123158-73-6)
• EPA Substance Registry System: 1-chloro-3-ethyl-5-nitroBenzene(123158-73-6)

Safety Data

• Hazardous Substances Data: 123158-73-6(Hazardous Substances Data)

Usage

Physical state

Yellow crystalline solid

Solubility

Insoluble in water, soluble in organic solvents

Uses

Intermediate in the synthesis of pharmaceuticals, agrochemicals, and dyes; key building block in the production of other aromatic compounds

Toxicity

Toxic if ingested or inhaled

Hazards

May cause skin and eye irritation upon contact

Safety measures

Handle with caution, use proper safety measures in laboratory or industrial settings

Upstream product

• 589-16-2 4-aminoethylbenzene 
• 3663-35-2 4-ethyl-2-nitroaniline 
• 123158-72-5 6-chloro-4-ethyl-2-nitroaniline 

Relevant articles and documents

Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders

4-Oxo-1,4-dihydroquinoline compounds having a 2-acidic group or a group convertible thereto in vivo, and their pharmaceutically acceptable salts, are potent specific antagonists of N-methyl-D-aspartate (NMDA) receptors and are therefore useful in the treatment of neurodegenerative disorders. 4-Oxo-1,4-dihydroquinoline compounds having a 2-acidic group or a group convertible thereto in vivo, other than carboxy or C 1-6 alkoxycarbonyl, are novel compounds, as also are compounds of formula II STR1 wherein R 2 represents carboxy or a group convertible thereto in vivo, R 6 is hydrogen and R 5 and R 7 represent C 1-6 alkyl or halogen, provided that R 5 and R 7 are not simultaneously chlorine or simultaneously bromine; a process for preparing the novel compounds is described, as also are pharmaceutical compositions containing the novel compounds.